Dexlansoprazole: delayed-release orally disintegrating tablets for the treatment of heartburn associated with non-erosive gastroesophageal reflux disease and the maintenance of erosive esophagitis-Reference-Cited by-同舟云学术

Dexlansoprazole: delayed-release orally disintegrating tablets for the treatment of heartburn associated with non-erosive gastroesophageal reflux disease and the maintenance of erosive esophagitis

Published:2016-09-22 Issue:10 Volume:10 Page:1083-1089
ISSN:1747-4124
Container-title:Expert Review of Gastroenterology & Hepatology
language:en
Short-container-title:Expert Review of Gastroenterology & Hepatology

Author:

Oldfield Edward C.,Parekh Parth J.,Johnson David A.

Publisher

Informa UK Limited

Subject

Gastroenterology,Hepatology

Link

http://www.tandfonline.com/doi/pdf/10.1080/17474124.2016.1230496

Reference40 articles.

1. Obesity and GERD

2. Review article: acid-related disease - what are the unmet clinical needs?

3. Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results

4. Long-Term Quality of Life Improvement in Subjects with Healed Erosive Esophagitis: Treatment with Lansoprazole

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Formulation Advances and Therapeutic Usefulness of Orally Disintegrating Tablets (ODTs);Pharmacy;2020-10-10

2. Pharmacokinetic/Pharmacodynamic Evaluation of Dexlansoprazole Infusion Injection Compared with Lansoprazole in Healthy Chinese Adults;Clinical Drug Investigation;2019-07-23

3. Perspectives on the interlinked nature of systemic sclerosis and reflux disease;Expert Review of Gastroenterology & Hepatology;2019-01-04

4. Potent Acid Suppression with PPIs and P-CABs: What’s New?;Current Treatment Options in Gastroenterology;2018-10-25

5. Interchangeable Use of Proton Pump Inhibitors Based on Relative Potency;Clinical Gastroenterology and Hepatology;2018-06